Received: 9 January 2024 | Accepted: 13 February 2024 | Marc W. Van Goethem, Ramona Marasco, Pei-Ying Hong, Daniele Daffonchio
The article "The antibiotic crisis: On the search for novel antibiotics and resistance mechanisms" by Marc W. Van Goethem, Ramona Marasco, Pei-Ying Hong, and Daniele Daffonchio highlights the urgent need to address the growing threat of antibiotic resistance. The authors emphasize that the proliferation of antibiotic-resistant bacteria is a critical issue that could lead to a global healthcare crisis, potentially causing tens of millions of deaths annually by 2050. Despite recent breakthroughs in antimicrobial peptide discovery and the use of artificial intelligence for chemotype screening, the discovery of new antibiotics has stagnated, leading to a "antibiotic discovery void."
The article suggests that the solution lies in exploring microbial niches, particularly in highly competitive environments such as the plant rhizosphere, biological soil crusts, deep-sea hydrothermal vents, and marine snow. These environments are characterized by intense microbial competition for resources, which drives the evolution of unique antibiotic-producing microorganisms. The authors argue that these "microbial oases of interactions" could yield novel antibiotics with high efficacy against multidrug-resistant bacteria.
The article also discusses the mechanisms of antibiotic resistance, including the role of antimicrobial resistance genes (ARGs) and the "arms race" between antibiotics and resistant bacteria. It highlights the importance of monitoring the environmental influx of ARGs, known as resistome surveillance, to track the spread of resistance and identify new antibiotic targets.
Additionally, the authors explore alternative approaches to antibiotic therapy, such as phage therapy, which uses bacteriophages to target specific bacterial pathogens. Phage therapy is proposed as a viable alternative to antibiotics, particularly for treating multidrug-resistant infections.
Finally, the article outlines strategies to combat the antibiotic crisis, including the search for novel antibiotics in microbial oases, responsible antibiotic stewardship, the development of alternative antimicrobial strategies, and regulatory measures to control antibiotic use. The authors conclude that a multifaceted approach is necessary to address the global challenge of antibiotic resistance and protect human health.The article "The antibiotic crisis: On the search for novel antibiotics and resistance mechanisms" by Marc W. Van Goethem, Ramona Marasco, Pei-Ying Hong, and Daniele Daffonchio highlights the urgent need to address the growing threat of antibiotic resistance. The authors emphasize that the proliferation of antibiotic-resistant bacteria is a critical issue that could lead to a global healthcare crisis, potentially causing tens of millions of deaths annually by 2050. Despite recent breakthroughs in antimicrobial peptide discovery and the use of artificial intelligence for chemotype screening, the discovery of new antibiotics has stagnated, leading to a "antibiotic discovery void."
The article suggests that the solution lies in exploring microbial niches, particularly in highly competitive environments such as the plant rhizosphere, biological soil crusts, deep-sea hydrothermal vents, and marine snow. These environments are characterized by intense microbial competition for resources, which drives the evolution of unique antibiotic-producing microorganisms. The authors argue that these "microbial oases of interactions" could yield novel antibiotics with high efficacy against multidrug-resistant bacteria.
The article also discusses the mechanisms of antibiotic resistance, including the role of antimicrobial resistance genes (ARGs) and the "arms race" between antibiotics and resistant bacteria. It highlights the importance of monitoring the environmental influx of ARGs, known as resistome surveillance, to track the spread of resistance and identify new antibiotic targets.
Additionally, the authors explore alternative approaches to antibiotic therapy, such as phage therapy, which uses bacteriophages to target specific bacterial pathogens. Phage therapy is proposed as a viable alternative to antibiotics, particularly for treating multidrug-resistant infections.
Finally, the article outlines strategies to combat the antibiotic crisis, including the search for novel antibiotics in microbial oases, responsible antibiotic stewardship, the development of alternative antimicrobial strategies, and regulatory measures to control antibiotic use. The authors conclude that a multifaceted approach is necessary to address the global challenge of antibiotic resistance and protect human health.